Dr. Luis A. Pagan, MD
General Practice (General Practice Physician)
At a glance
- Years since graduation
- 38
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
General Practice Physician primary
PR license 12215
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 2 companies reported 25 payments worth $4,384 in total to this clinician.
| Eli Lilly and Company | $4,290 |
|---|---|
| Novo Nordisk Inc | $94.15 |
| Travel and Lodging | $4,254 |
|---|---|
| Food and Beverage | $94.15 |
| Education | $36.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $2,546 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $218 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $197 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $98.00 |
| Eli Lilly and Company Apr 16, 2025 | Education in-kind | $36.00 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $32.37 |
All 24 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $2,546 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $249 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $218 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $197 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $98.00 |
| Eli Lilly and Company Apr 16, 2025 | Education in-kind | $36.00 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $32.37 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $17.43 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $17.43 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $17.43 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $16.97 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $15.30 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $14.94 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $14.94 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind | $14.94 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $11.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $7.65 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $4.99 |
| Eli Lilly and Company Apr 16, 2025 | Travel and Lodging travel to MIAMI, FL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A RESEARCH RELATED MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $2.49 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 8 industry-funded studies in 2025, from 3 companies. The companies reported $1,082,786 in research payments for these studies, mostly to the institutions running them.
- A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Eli Lilly and Company · Active, not recruiting · NCT05869903 - Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
Eli Lilly and Company · Completed · NCT06354660 - A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes
Eli Lilly and Company · Active, not recruiting · NCT05433584 - A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
Eli Lilly Export S.a. Puerto Rico Branch · Active, not recruiting · NCT06948422 - A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
Eli Lilly and Company · Active, not recruiting · NCT05556512 - A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Eli Lilly and Company · Completed · NCT05803421 - A master protocol to investigate the efficacy and safety of orforglipron once daily in participants with hypertension and obesity or overweight: randomized, double-blind, placebo-controlled trials (attain-hypertension…
Eli Lilly and Company - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in p…
Boehringer Ingelheim International GmbH
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.